Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 15
1993 15
1994 8
1995 13
1996 8
1997 6
1998 3
1999 3
2000 2
2001 3
2002 3
2003 5
2004 4
2005 1
2006 3
2007 4
2008 1
2009 2
2010 3
2011 4
2012 2
2013 2
2014 2
2015 1
2016 1
2017 3
2018 4
2019 2
2020 1
2021 2
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Pignata S, Lorusso D, Joly F, Gallo C, Colombo N, Sessa C, Bamias A, Salutari V, Selle F, Frezzini S, De Giorgi U, Pautier P, Bologna A, Orditura M, Dubot C, Gadducci A, Mammoliti S, Ray-Coquard I, Zafarana E, Breda E, Favier L, Ardizzoia A, Cinieri S, Largillier R, Sambataro D, Guardiola E, Lauria R, Pisano C, Raspagliesi F, Scambia G, Daniele G, Perrone F; MITO16b/MANGO–OV2/ENGOT–ov17 Investigators. Pignata S, et al. Among authors: ardizzoia a. Lancet Oncol. 2021 Feb;22(2):267-276. doi: 10.1016/S1470-2045(20)30637-9. Lancet Oncol. 2021. PMID: 33539744 Clinical Trial.
Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study.
Conti M, Bolzacchini E, Luchena G, Bertu' L, Tagliabue P, Aglione S, Ardizzoia A, Arnoffi J, Guida FM, Bertolini A, Pastorini A, Duro M, Bettega D, Roda' G, Artale S, Squizzato A, Giordano M. Conti M, et al. Among authors: ardizzoia a. Cancers (Basel). 2023 Jul 2;15(13):3465. doi: 10.3390/cancers15133465. Cancers (Basel). 2023. PMID: 37444575 Free PMC article.
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype.
Sala L, Cirillo G, Riva G, Romano G, Giussani C, Cialdella A, Todisco A, Virtuoso A, Cerrito MG, Bentivegna A, Grassilli E, Ardizzoia A, Bonoldi E, Giovannoni R, Papa M, Lavitrano M. Sala L, et al. Among authors: ardizzoia a. Front Mol Neurosci. 2019 Jan 24;12:2. doi: 10.3389/fnmol.2019.00002. eCollection 2019. Front Mol Neurosci. 2019. PMID: 30733667 Free PMC article.
A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study.
Parente F, Marino B, Ilardo A, Fracasso P, Zullo A, Hassan C, Moretti R, Cremaschini M, Ardizzoia A, Saracino I, Perna F, Vaira D. Parente F, et al. Among authors: ardizzoia a. Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1145-52. doi: 10.1097/MEG.0b013e328355cc79. Eur J Gastroenterol Hepatol. 2012. PMID: 22735608
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience.
Soatti CP, Delishaj D, D'Amico R, Frigerio C, Fumagalli IC, Bonsignore F, Sangalli G, Declich F, Arcangeli S, Ardizzoia A, Colombo A. Soatti CP, et al. Among authors: ardizzoia a. J Contemp Brachytherapy. 2020 Dec;12(6):533-539. doi: 10.5114/jcb.2020.101685. Epub 2020 Dec 16. J Contemp Brachytherapy. 2020. PMID: 33437300 Free PMC article.
Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial.
Dimopoulos M, Weisel K, van de Donk NWCJ, Ramasamy K, Gamberi B, Streetly M, Offidani M, Bridoux F, de la Rubia J, Mateos MV, Ardizzoia A, Kueenburg E, Collins S, Di Micco A, Rosettani B, Li Y, Bacon P, Sonneveld P. Dimopoulos M, et al. Among authors: ardizzoia a. J Clin Oncol. 2018 Jul 10;36(20):2035-2043. doi: 10.1200/JCO.2017.76.1742. Epub 2018 Feb 2. J Clin Oncol. 2018. PMID: 29394124 Clinical Trial.
Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.
Fallai C, Bolner A, Signor M, Gava A, Franchin G, Ponticelli P, Taino R, Rossi F, Ardizzoia A, Oggionni M, Crispino S, Olmi P. Fallai C, et al. Among authors: ardizzoia a. Tumori. 2006 Jan-Feb;92(1):41-54. doi: 10.1177/030089160609200108. Tumori. 2006. PMID: 16683383 Clinical Trial.
125 results